Anavex Life Sciences Corp (AVXL)

[falconer66a]

Experts, Tell How Anavex 2-73 Fails FDA Approval

From Jonjones' shareholder meeting notes:

Genomic signature found and to be reported at an upcoming conference. The signature allows them to accurately predict who will benefit most from 2-73. This way the data can be used in all future trials.

1. A genomic (DNA) signature has been found correlating to efficacy; thereby accurately predicting such.

2. Details to be announced at an upcoming conference.

3. Those who benefit most from Anavex 2-73 can now be predicted, detected, and selected.

4. Future Anavex 2-73 clinical trials will, necessarily and favorably, include only those pre-detected to have the DNA, genes, that respond positively to the molecule.

Jonjones, thanks so much for posting this seminal information.

With all of this, anyone want to tell us just how Anavex 2-73 fails the upcoming clinical trial for Alzheimer’s treatment and consequent FDA approval? Fill us in, please.